Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Shared Decision Making and Health-Related Quality of Life in the Diagnosis and Management of Patients with Inborn Errors of Immunity.

The journal of allergy and clinical immunology. In practice·2026

Same author

Practice parameter for inborn errors of immunity: What is new in the 2025 update.

The Journal of allergy and clinical immunology·2026

Same author

Immunoglobulin replacement therapy in primary immunodeficiency disorders: Pragmatic review and evidence mapping.

The journal of allergy and clinical immunology. Global·2026

Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Same author

What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.

The journal of allergy and clinical immunology. In practice·2026

Same author

Emergency front of neck access in the setting of paediatric trauma.

Emergency medicine journal : EMJ·2026

Search research articles

Related Experiment Video

Updated: Aug 25, 2025

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

A validated artificial intelligence-based pipeline for population-wide primary immunodeficiency screening.

Nicholas L Rider¹, Michael Coffey², Ashok Kurian²

¹Division of Clinical Informatics, Liberty University College of Osteopathic Medicine and the Liberty Mountain Medical Group, Lynchburg, Va.

The Journal of Allergy and Clinical Immunology

|October 15, 2022

Summary

This study developed a two-step pipeline using machine learning to identify individuals at risk for primary immunodeficiency and infection susceptibility, improving diagnostic rates and patient outcomes.

Keywords:

Primary immunodeficiency augmented/artificial intelligence clinical data science inborn error of immunity learning health system machine learning public health

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Experiment Videos

Last Updated: Aug 25, 2025

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Area of Science:

Immunology
Data Science
Medical Informatics

Background:

Diagnosing inborn errors of immunity and infection susceptibility is challenging.
Delayed diagnosis leads to increased patient morbidity and poorer outcomes.
Systematic methods are needed to improve diagnostic rates for primary immunodeficiency.

Purpose of the Study:

To develop and validate a generalizable analytical pipeline for population-wide detection of infection susceptibility.
To identify individuals at risk for primary immunodeficiency.

Main Methods:

A prospective, longitudinal cohort study analyzed claims data from 427,110 individuals over 30 months.
A machine learning classifier was coupled with weighted rules for risk stratification.
The study adhered to TRIPOD standards for reporting prediction models.

Main Results:

High-risk individuals were significantly more likely to be diagnosed with primary immunodeficiency (9% vs. 1.5% vs. 0.2%).
Machine learning stratification provided an annualized risk assessment for triaging referrals.
The top-performing model achieved an area under the receiver-operator characteristic curve of 0.98 and an F1 score of 0.98.

Conclusions:

A two-step analytical pipeline can effectively identify individuals with primary immunodeficiency.
This approach accurately quantifies clinical risk, facilitating earlier diagnosis and intervention.